尊龙凯时人生就是赢(中国)官方网站尊龙凯时

尊龙凯时药业
DP Technology Platforms
Controlled-release Formulation Development Taste Masking Technology Particle Flow Simulation
Controlled-release Formulation Development Platform
Controlled-release formulations control the action of drugs by regulating the rate and duration of drug release, thereby reducing dosing frequency and enhancing the safety, efficacy, reliability, and convenience of drug therapy, ultimately improving patient compliance. With the improvement of economic levels and the development of the pharmaceutical industry, the importance of controlled-release drug technology continues to increase. The construction of controlled-release formulation technology platforms will continuously enable the company to develop high technological barriers for controlled-release products, providing ample technical support for future market competition.
尊龙凯时药业
Research Fields
尊龙凯时药业
Pellet sustained and controlled release technology
Film controlled coating technology
Hydrophilic gel matrix sustained-release tablets
Insoluble matrix sustained-release tablets
Selected Projects
尊龙凯时药业
Metoprolol succinate sustained-release tablets: sustained-release pellets, pellet compressed tablets Bupropion Hydrochloride Sustained Release Tablets, APF2003: Controlled Coating Technology AF22207, AF23204: Hydrophilic gel matrix sustained-release tablets AF23216: Insoluble matrix sustained-release tablets
尊龙凯时药业
尊龙凯时药业
尊龙凯时药业
尊龙凯时药业
尊龙凯时